Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

MSVEX vs. RPAR: which is better?

Bottom line

MSVEX vs RPAR: the short answer

MSVEX (Vitality Portfolio) and RPAR (RPAR Risk Parity ETF) are both mutual funds.

RPAR is cheaper at 0.52% vs 1.3% — a difference of $78 a year per $10,000 invested.

Over one year, RPAR returned +18.3% vs +8.7% for MSVEX.

MSVEX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

MSVEX vs RPAR side by side

MSVEXRPAR
TypeMutual fundETF
Fund familyMorgan StanleyFranklin Templeton
CategoryOtherOther
Expense ratio1.3%0.52%
Annual cost per $10k$130$52
10-yr cost on $10k (prospectus)$10,017$653
Max front load5.25%None
12b-1 fee0.25%0%
1-yr return+8.7%+18.3%
5-yr return (annualized)—+0.9%
10-yr return (annualized)——
Best quarter—+11.0%
Worst quarter—−15.8%
Net assets (fund)—$586.0M
Number of holdings—149
Portfolio turnover27%17%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

MSVEX and RPAR share none of their top holdings.

MSVEX top 10

    RPAR top 10

    1. Vanguard Total Stock Market ET — 12.84%
    2. Treasury Bill — 11.72%
    3. SPDR Gold MiniShares Trust — 9.28%
    4. Vanguard FTSE Emerging Markets — 7.71%
    5. First American Government Obli — 5.92%
    6. Vanguard FTSE Developed Market — 5.13%
    7. United States Treasury Inflation Indexed Bonds — 3.83%
    8. Tsy Infl Ix N/b — 3.26%
    9. Tsy Infl Ix N/b — 3.25%
    10. United States Treasury Inflation Indexed Bonds — 3.12%

    FAQ

    What is the difference between MSVEX and RPAR?
    MSVEX (Vitality Portfolio) and RPAR (RPAR Risk Parity ETF) are both mutual funds. RPAR is cheaper at 0.52% vs 1.3% — a difference of $78 a year per $10,000 invested.
    Which is cheaper, MSVEX or RPAR?
    RPAR has the lower expense ratio (0.52%).
    Should I own both MSVEX and RPAR?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.